CPC C12Q 1/48 (2013.01) [C07K 14/4708 (2013.01); C12N 9/1007 (2013.01); C12N 9/1014 (2013.01); C12N 9/107 (2013.01); C12N 9/1096 (2013.01); C12Q 1/527 (2013.01); C12Y 201/01005 (2013.01); G01N 33/53 (2013.01)] | 7 Claims |
1. A method for measuring the amount of an acetaminophen-protein adduct comprising a protein bound to acetaminophen in a biological sample, the method comprising:
a) providing a biological sample from a subject having or suspected of having acetaminophen toxicity;
b) contacting the sample with a first antibody specific to the protein to form a first complex between the first antibody and the protein, wherein the protein is selected from the group consisting of betaine-homocysteine S-methyltransferase 1, cytoplasmic aspartate aminotransferase, 1,4-alpha-glucan-branching enzyme, formimidoyltransferase-cyclodeaminase, and dystrophin;
c) isolating the first complex;
d) contacting the isolated first complex with a second antibody specific to a 3-(cystein-S-yl) APAP (3-Cys-A)-protein linkage on the acetaminophen-protein adduct to form a second complex;
e) measuring the amount of the second complex, wherein the amount of the second complex is indicative of the amount of the acetaminophen-protein adduct.
|